Metamark, BCBS of Texas Announce Agreement
News Jul 13, 2016
Metamark Genetics, Inc. has announced that it has signed an agreement with Blue Cross and Blue Shield of Texas (BCBSTX) to provide its members with in-network access to Metamark’s offering of urology specialized diagnostics.
“Metamark is delighted to be recognized as an in-network provider with Blue Cross and Blue Shield of Texas. Our continued momentum with payers across the US reflects the substantial value our comprehensive suite of products and services provides to patients, physicians, and insurers” said Jerry Williamson, president and chief executive officer.
“We maintain our strong commitment to improve the care of patients with urologic cancer by expanding access to vital, decision-making information throughout the complete diagnostic and therapeutic care journey.”
Metamark has previously announced in-network agreements with additional large Blue Cross and Blue Shield Plans and also has agreements in place with the largest PPO networks in the country.
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018